Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,081 papers from all fields of science
Search
Sign In
Create Free Account
SGN 40
Known as:
SGN-14
, SGN40 cpd
, Monoclonal Antibody SGN-14
Expand
A humanized monoclonal antibody targeting the CD40 antigen with potential antineoplastic activity. CD-40, an integral membrane protein found on the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
NCIt Antineoplastic Agent Terminology
antigen binding
Broader (1)
dacetuzumab
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Enhanced T-cell-independent Antitumor Effect of Cyclophosphamide Combined With Anti-CD40 mAb and CpG in Mice
Erik E. Johnson
,
I. Buhtoiarov
,
+4 authors
A. Rakhmilevich
Journal of immunotherapy
2011
Corpus ID: 24377699
We have earlier demonstrated T-cell-independent antitumor effects of a combination of anti-CD40 monoclonal antibody (mAb) and CpG…
Expand
2009
2009
Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.
E. Agura
,
R. Niesvizky
,
+7 authors
J. Zonder
2009
Corpus ID: 79388039
Abstract 2870 Poster Board II-846 Background: Dacetuzumab (SGN-40) is a humanized monoclonal antibody that targets CD40. In prior…
Expand
Review
2008
Review
2008
Manipulating B cell homeostasis: a key component in the advancement of targeted strategies
L. S. Treml
,
W. Quinn
,
J. Treml
,
Jean L. Scholz
,
M. Cancro
Archivum Immunologiae et Therapiae Experimentalis
2008
Corpus ID: 2421396
Understanding the homeostatic mechanisms governing lymphocyte pools achieves critical importance as lymphocyte-targeted therapies…
Expand
2005
2005
A Phase I Humanized Anti-CD40 Monoclonal Antibody (SGN-40) in Patients with Multiple Myeloma.
M. Hussein
,
J. Berenson
,
+4 authors
J. Drachman
2005
Corpus ID: 78542015
SGN-40, a humanized anti-CD40 monoclonal antibody, is being evaluated in a phase I dose escalation study for patients with…
Expand
2005
2005
A Phase I Study of Humanized Anti-CD40 Immunotherapy with SGN-40 in Non-Hodgkin’s Lymphoma.
R. Advani
,
R. Furman
,
+6 authors
J. Drachman
2005
Corpus ID: 78237584
The vast majority of B-cell malignancies express CD40, a member of the TNF receptor family. This receptor, along with the cognate…
Expand
2000
2000
Synthetic oligodeoxynucleotides inhibit IgE induction in human lymphocytes.
S. Fujieda
,
S. Iho
,
Y. Kimura
,
H. Yamamoto
,
H. Igawa
,
H. Saito
American Journal of Respiratory and Critical Care…
2000
Corpus ID: 45296805
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs have the capacity to stimulate T-helper (Th)1-type…
Expand
2000
2000
Differential expression of the B cell‐restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation
D. Viemann
,
P. Schlenke
,
H. Hammers
,
H. Kirchner
,
A. Kruse
European Journal of Immunology
2000
Corpus ID: 27270012
Newborns respond poorly to certain antigens and produce mainly IgM antibodies. By flow cytometry we analyzed on neonatal and…
Expand
1996
1996
B cell‐B cell interaction through intercellular adhesion molecule‐1 and lymphocyte functional antigen‐1 regulates immunoglobulin E synthesis by B cells stimulated with interleukin‐4 and anti‐CD40…
Y. Katada
,
Toshio Tanaka
,
+5 authors
T. Kishimoto
European Journal of Immunology
1996
Corpus ID: 45902393
IgE synthesis by purified human B cells is induced by two signals: a class switching factor, most commonly interleukin (IL)‐4…
Expand
1994
1994
Role of protein tyrosine kinases in CD40/interleukin-4-mediated isotype switching to IgE.
R. Loh
,
H. Jabara
,
C. Ren
,
S. Fu
,
R. Geha
Journal of Allergy and Clinical Immunology
1994
Corpus ID: 37289730
Highly Cited
1993
Highly Cited
1993
Induction by anti‐CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X‐linked hyper IgM syndrome
A. Durandy
,
C. Schiff
,
+5 authors
Alain Fischer
European Journal of Immunology
1993
Corpus ID: 23796217
We studied the ability of B lymphocytes from patients with X‐linked hyper IgM syndrome (HIGM1) to be activated via the CD40…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required